GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry. http://www.researchmoz.us/partnerships-licensing-investments-and-manda-deals-and-trends-for-april-2015-in-pharmaceuticals-report.html

1. Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals
Summary
GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals report is an essential source of data and trend
analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on
partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in April
2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas,
and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex
hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders,
musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the
pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner
- Find out the major deal performing segments for investments in your industry
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry
- Identify growth segments and opportunities in each region within the industry
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry
1 Table Of Contents
1 Table Of Contents 2
1.1 List Of Tables 6
1.2 List Of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, April 2015 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, April 2015 14
2.2.1 Mylan To Acquire Perrigo 14
2.2.2 Daiichi Sankyo Raises Usd3.6 Billion In Public Offering Of Shares Of Sun Pharma 15
2.2.3 Ventas To Acquire Ardent Medical Services For Usd1.75 Billion 16
2.2.4 Davita Healthcare Prices Public Offering Of 5% Notes Due 2025 For Usd1.5 Billion 16
2.2.5 Innate Pharma Enters Into Co-development Agreement With Astrazeneca For Immuno-oncology 18
2.3 Pharmaceuticals & Healthcare, Global, By Type, Number Of Deals, April 2015 19
2.4 Pharmaceuticals & Healthcare, Global, By Type, Deal Values, April 2015 20
3 Pharmaceuticals And Healthcare, Global, Deals, Summary, By Type 21
3.1 Pharmaceuticals & Healthcare, Global, M&a, April 2015 21
3.1.1 Top M&a Deals In April 2015 22
3.1.2 Pharmaceuticals & Healthcare, Global, M&a Deals By Therapy Area, November 2014 - April 2015 23
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, April 2015 25
3.2.1 Top Equity Offering Deals In April 2015 26
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals By Therapy Area, November 2014 - April 2015 27
3.3 Pharmaceuticals & Healthcare, Global, Private Equity And Venture Capital Deals, April 2015 29
3.3.1 Top Pe/vc Deals In April 2015 30
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals

2. 3.3.2 Pharmaceuticals & Healthcare, Global, Pe/vc By Therapy Area, April 2015 31
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals By Stage Of Financing, April 2015 32
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, November 2014-april 2015 34
3.3.5 Pharmaceuticals & Healthcare, Global, Top Vc Backed Companies, November 2014-april 2015 35
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, April 2015 36
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, April 2015 36
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals By Therapy Area, November 2014 - April 2015 38
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals By Upfront And Milestone Payments And Deal Values (us$ M), April 2015 40
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals By Payment Mode, April 2015 41
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals By Therapy Area, By Upfront And Milestone Payments And Deal Values (us$ M), November 2014
- April 2015 42
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, Number Of Deals, November 2014 - April 2015 44
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, Deal Values (us$ M), November 2014 - April 2015 45
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, By Upfront & Milestone Payments And Deal Values (us$ M), November 2014 - April
2015 47
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2015 49
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, April 2015 49
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront And Milestone Payments And Deal Values (us$ M), April 2015 51
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Therapy Area, Total Deal Values (us$ M), November 2014 - April 2015 53
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Therapy Area, Upfront Payments And Milestone Payments (us$ M), November 2014 -
April 2015 55
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Phase, Total Deal Values (us$ M), November 2014 - April 2015 57
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Phase, Upfront Payments And Milestone Payments (us$ M), November 2014 - April
2015 60
5.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements By Deal Value, April 2015 61
5.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, By Total Upfront Payments, April 2015 62
5.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements By Total Milestone Payment, April 2015 62
6 Pharmaceuticals & Healthcare, Global, Deal Summary By Therapy Area 63
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, April 2015 63
6.1.1 Oncology - Deals Of The Month 65
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, April 2015 67
6.2.1 Central Nervous System - Deals Of The Month 69
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, April 2015 70
6.3.1 Infectious Diseases - Deals Of The Month 72
6.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, April 2015 73
6.4.1 Cardiovascular - Deals Of The Month 74
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, April 2015 76
6.5.1 Immunology - Deal Of The Month 77
6.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, April 2015 78
6.6.1 Gastrointestinal - Deals Of The Month 80
6.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, April 2015 81
6.7.1 Metabolic Disorders - Deal Of The Month 83
7 Deal Summary By Geography 84
7.1 Pharmaceuticals & Healthcare, North America Deals, April 2015 84
7.1.1 North America - Deals Of The Month 86
7.2 Pharmaceuticals & Healthcare, Europe, Deals, April 2015 88
7.2.1 Europe - Deals Of The Month 90
7.3 Pharmaceuticals & Healthcare, Asia-pacific, Regional Deals, April 2015 93
7.3.1 Asia-pacific - Deals Of The Month 95
7.4 Pharmaceuticals & Healthcare, Rest Of The World, Deals, April 2015 96
7.4.1 Rest Of The World - Deals Of The Month 98
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 99
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&a, November 2014 - April 2015 99
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, November 2014 - April 2015 101
9 Further Information 103
9.1 Methodology 103
9.2 About Globaldata 104
9.3 Disclosure Information 105
9.4 Disclaimer 105
1.1 List Of Tables
table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 13
table 2: Pharmaceuticals & Healthcare, Global, Major Deals, April 2015 14
table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals And Deal Values (%), April 2015 20
table 4: Pharmaceuticals & Healthcare, Global, M&a, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 22
table 5: Pharmaceuticals & Healthcare, Global, Top M&a Deals, April 2015 22
table 6: Pharmaceuticals & Healthcare, Global, M&a, Deals Summary, Number Of Deals And Deal Values (us$ M), By Therapy Area, November 2014 - April
2015 24
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals

3. table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 26
table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, April 2015 26
table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 28
table 10: Pharmaceuticals & Healthcare, Global, Pe/vc, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 30
table 11: Pharmaceuticals & Healthcare, Global, Top Pe/vc Deals, April 2015 30
table 12: Pharmaceuticals & Healthcare, Global, Pe/vc Deals By Therapy Area, Deals Summary, November 2014 - April 2015 32
table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals By Stage Of Financing, Number Of Deals And Deal Values (%), April 2015 33
table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 34
table 15: Pharmaceuticals & Healthcare, Global, Top Vc Backed Companies, November 2014 - April 2015 35
table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 37
table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals By Therapy Area, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015
39
table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront And Milestone Payments And Deal Values (us$ M), November 2014 - April 2015 41
table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront And Milestone Payments And Deal Values (us$ M), April 2015 41
table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals By Therapy Area, Upfront And Milestone Payments And Deal Values (us$ M), November
2014 - April 2015 43
table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, November 2014 - April 2015 46
table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals By Upfront And Milestone Payment And Deal Values (us$ M), November 2014 - April 2015
48
table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 -
April 2015 50
table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront And Milestone Payments And Deal Values (us$ M), November
2014 - April 2015 52
table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Therapy Area, Number Of Deals And Deal Values (us$ M), November 2014 -
April 2015 54
table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements By Therapy Area, By Upfront And Milestone Payments (us$ M), April 2015 56
table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, November 2014 - April 2015 59
table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements By Therapy Area, By Upfront And Milestone Payments And Deal Values (us$ M), April
2015 61
table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals By Value, April 2015 61
table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals By Total Upfront Payments, April 2015 62
table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals By Total Milestone Payment, April 2015 62
table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 64
table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 68
table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015
71
table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 74
table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 77
table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 79
table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 82
table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 85
table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 89
table 41: Pharmaceuticals & Healthcare, Asia-pacific, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 94
table 42: Pharmaceuticals & Healthcare, Rest Of The World, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 97
table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&a, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 100
table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 102
1.2 List Of Figures
figure 1: Pharmaceuticals & Healthcare, Global, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 12
figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), April 2015 19
figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), April 2015 20
figure 4: Pharmaceuticals & Healthcare, Global, M&as, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 21
figure 5: Pharmaceuticals & Healthcare, Global, M&as By Therapy Area, Number Of Deals And Deal Values (us$ M), By Therapy Area, November 2014 - April
2015 23
figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 25
figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals By Therapy Area, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 27
figure 8: Pharmaceuticals & Healthcare, Global, Private Equity And Venture Capital, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015
29
figure 9: Pharmaceuticals & Healthcare, Global, Pe/vc Deals By Therapy Area, Number Of Deals And Deal Values (us$ M), By Therapy Area, November 2014 -
April 2015 31
figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals By Stage Of Financing, Number Of Deals (%), April 2015 32
figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals By Stage Of Financing, Deal Values (%), April 2015 33
figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 34
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals

4. figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 36
figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals By Therapy Area, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015
38
figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront And Milestone Payments And Deal Values (us$ M), November 2014 - April 2015
40
figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals By Therapy Area, Upfront And Milestone Payments And Deal Values (us$ M), November
2014 - April 2015 42
figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, November 2014 - April 2015 44
figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, November 2014 - April 2015 45
figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals By Phase, By Upfront & Milestone Payments And Deal Values (us$ M), November 2014 -
April 2015 47
figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 49
figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront And Milestone Payments And Deal Values (us$ M), November 2014 -
April 2015 51
figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Therapy Area, Number Of Deals And Deal Values (us$ M), November 2014 -
April 2015 53
figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Therapy Area, Upfront And Milestone Payments And Deal Values (us$ M),
November 2014 - April 2015 55
figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Phase, Number Of Deals, November 2014 - April 2015 57
figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Phase, Deal Values (us$ M), November 2014 - April 2015 58
figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals By Phase, By Upfront And Milestone Payments And Deal Values (us$ M), April
2015 60
figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 63
figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 67
figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 70
figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 73
figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 76
figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 78
figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 81
figure 34: Pharmaceuticals & Healthcare, North America, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 84
figure 35: Pharmaceuticals & Healthcare, Europe, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 88
figure 36: Pharmaceuticals & Healthcare, Asia-pacific, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 93
figure 37: Pharmaceuticals & Healthcare, Rest Of The World, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 96
figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&a, Number Of Deals And Deal Values (us$ M), November 2014 - April 2015 99
figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number Of Deals And Deal Values (us$ M), November 2014 - April
2015 101
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Partnerships, Licensing, Investments and M&A Deals and Trends for April 2015 in Pharmaceuticals